title: Engineering the acyltransferase substrate specificity of assembly line polyketide synthases.
abstract: Polyketide natural products act as a broad range of therapeutics, including antibiotics, immunosuppressants and anti-cancer agents. This therapeutic diversity stems from the structural diversity of these small molecules, many of which are produced in an assembly line manner by modular polyketide synthases. The acyltransferase (AT) domains of these megasynthases are responsible for selection and incorporation of simple monomeric building blocks, and are thus responsible for a large amount of the resulting polyketide structural diversity. The substrate specificity of these domains is often targeted for engineering in the generation of novel, therapeutically active natural products. This review outlines recent developments that can be used in the successful engineering of these domains, including AT sequence and structural data, mechanistic insights and the production of a diverse pool of extender units. It also provides an overview of previous AT domain engineering attempts, and concludes with proposed engineering approaches that take advantage of current knowledge. These approaches may lead to successful production of biologically active 'unnatural' natural products.
authors.affiliation: Department of Chemical Engineering, Stanford University, Stanford, CA, USA.
authors.forename: Briana J
authors.initials: BJ
authors.lastname: Dunn
authors.forename: Chaitan
authors.initials: C
authors.lastname: Khosla
mesh_terms: D000217:Acyltransferases / Q000737:chemistry / Q000235:genetics; D048630:Polyketide Synthases / Q000737:chemistry / Q000235:genetics; D015202:Protein Engineering / Q000379:methods*; D013379:Substrate Specificity
chemical_list: D048630:Polyketide Synthases; D000217:Acyltransferases
keywords: acyltransferase; antibiotics; enzyme engineering; polyketide